Sheng, L., Rigo, F., Bennett, C. F., Krainer, A. R., Hua, Y.
  
(April 2020)
Comparison of the Efficacy of MOE and PMO Modifications of Systemic Antisense Oligonucleotides in a Severe SMA Mouse Model.
    Nucleic Acids Research, 6 (48).
     pp. 2853-2865.
     ISSN 0305-1048
     (Public Dataset)
  
  
  
  
  
    
  
    
      
      
    
  
  
    
  
  
    
  
  
    Abstract
    Spinal muscular atrophy (SMA) is a motor neuron disease. Nusinersen, a splice-switching antisense oligonucleotide (ASO), was the first approved drug to treat SMA. Based on prior preclinical studies, both 2'-O-methoxyethyl (MOE) with a phosphorothioate backbone and morpholino with a phosphorodiamidate backbone-with the same or extended target sequence as nusinersen-displayed efficient rescue of SMA mouse models. Here, we compared the therapeutic efficacy of these two modification chemistries in rescue of a severe mouse model using ASO10-29-a 2-nt longer version of nusinersen-via subcutaneous injection. Although both chemistries efficiently corrected SMN2 splicing in various tissues, restored motor function and improved the integrity of neuromuscular junctions, MOE-modified ASO10-29 (MOE10-29) was more efficacious than morpholino-modified ASO10-29 (PMO10-29) at the same molar dose, as seen by longer survival, greater body-weight gain and better preservation of motor neurons. Time-course analysis revealed that MOE10-29 had more persistent effects than PMO10-29. On the other hand, PMO10-29 appears to more readily cross an immature blood-brain barrier following systemic administration, showing more robust initial effects on SMN2 exon 7 inclusion, but less persistence in the central nervous system. We conclude that both modifications can be effective as splice-switching ASOs in the context of SMA and potentially other diseases, and discuss the advantages and disadvantages of each.
  
  
    
      | Item Type: | Paper | 
    
    
      
    
      
    
      
    
      
        
          | Subjects: | bioinformatics bioinformatics > genomics and proteomics > genetics & nucleic acid processing > DNA, RNA structure, function, modification > DNA expression
 bioinformatics > genomics and proteomics > genetics & nucleic acid processing > DNA, RNA structure, function, modification
 bioinformatics > genomics and proteomics > genetics & nucleic acid processing
 bioinformatics > genomics and proteomics
 bioinformatics > genomics and proteomics > genetics & nucleic acid processing > DNA, RNA structure, function, modification > Alternative Splicing
 organism description > animal
 organs, tissues, organelles,  cell types and functions > cell types and functions > cell types
 organs, tissues, organelles,  cell types and functions > cell types and functions > cell types
 organs, tissues, organelles,  cell types and functions > cell types and functions > cell types
 organs, tissues, organelles,  cell types and functions > cell types and functions
 bioinformatics > genomics and proteomics > genetics & nucleic acid processing > DNA, RNA structure, function, modification > exons
 organism description > animal > mammal
 organs, tissues, organelles,  cell types and functions > cell types and functions > cell types > neurons > motor neurons
 organs, tissues, organelles,  cell types and functions > cell types and functions > cell types > neurons > motor neurons
 organs, tissues, organelles,  cell types and functions > cell types and functions > cell types > neurons > motor neurons
 organism description > animal > mammal > rodent > mouse
 organs, tissues, organelles,  cell types and functions > sub-cellular tissues: types and functions > neuromuscular junction
 organs, tissues, organelles,  cell types and functions > cell types and functions > cell types > neurons
 organs, tissues, organelles,  cell types and functions > cell types and functions > cell types > neurons
 organs, tissues, organelles,  cell types and functions > cell types and functions > cell types > neurons
 bioinformatics > genomics and proteomics > genetics & nucleic acid processing > DNA, RNA structure, function, modification > oligonucleotide
 organs, tissues, organelles,  cell types and functions
 bioinformatics > genomics and proteomics > genetics & nucleic acid processing > DNA, RNA structure, function, modification > RNA splicing
 organism description > animal > mammal > rodent
 diseases & disorders > congenital hereditary genetic diseases > spinal muscular atrophy
 organs, tissues, organelles,  cell types and functions > sub-cellular tissues: types and functions
 | 
      
    
      
        
          | CSHL Authors: |  | 
      
    
      
        
          | Communities: | CSHL labs > Krainer lab CSHL Cancer Center Program > Gene Regulation and Inheritance Program
 | 
      
    
      
    
      
    
      
        
          | Depositing User: | Adrian Gomez | 
      
    
      
        
          | Date: | 6 April 2020 | 
      
    
      
        
          | Date Deposited: | 06 Apr 2020 14:26 | 
      
    
      
        
          | Last Modified: | 01 Feb 2024 18:30 | 
      
    
      
        
          | PMCID: | PMC7102994 | 
      
    
      
        
          | Related URLs: |  | 
      
    
      
        
          | Dataset ID: | https://academic.oup.com/nar/article/48/6/2853/5760755#supplementary-data
 | 
      
    
    
      | URI: | https://repository.cshl.edu/id/eprint/39225 | 
  
  
  
  
    Actions (login required)
    
    
      
        |  | Administrator's edit/view item |